AACR 2011: Major Symposia: TCGA: Discovery and Innovation in Cancer Genomics
April 05, 2011 4:30 PM - 6:30 PM
Orange County Convention Center: Room West Hall F3/F4, Orlando, Florida
Cancer is a disease of the genes; hence a complete and accurate view of the cancer genome holds the potential to:
- provide penetrating insight into the genetic bases of cancer
- identify promising candidate therapeutic targets and diagnostic biomarkers
- illuminate the path toward personalized cancer medicine
The goal of TCGA is to generate such comprehensive catalogs of somatic genomic alterations in diverse cancers. This session will highlight recent discoveries and innovations by TCGA in areas of genomic technology, computational science and cancer genetics.
Session Chair: Lynda Chin, M.D., Broad Institute, Cambridge, Mass.
- NGS Enables Transformative Inquiry into Complexity of Cancer: Elaine Mardis, Ph.D., The Genome Center at Washington University, St. Louis, Mo.
- Cross-Tumor Genomics Reveal New Cancer Biological Insights: Gad Getz, Ph.D., Broad Institute, Cambridge, Mass.
- Pathway Analysis Integrates Multi-Dimensional Genomic Data: Joshua Stuart, Ph.D., University of California at Santa Cruz, Calif.
- New Insights into Somatic Genomics and Epigenomics of CRC: Raju Kucherlapati, Ph.D., Brigham and Women’s Hospital/Harvard Medical School, Boston, Mass.